Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy
Filip Van den Bosch, Elli Kruithof, Dominique Baeten, Annemie Herssens, Filip de Keyser, Herman Mielants, Eric M. VeysVolume:
46
Year:
2002
Language:
english
Pages:
11
DOI:
10.1002/art.511
File:
PDF, 128 KB
english, 2002